William Blair & Company’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-18,165
Closed -$435K 2021
2026
Q1
$435K Buy
18,165
+1,291
+8% +$31.6K ﹤0.01% 1199
2025
Q4
$382K Sell
16,874
-18,201
-52% -$396K ﹤0.01% 1227
2025
Q3
$706K Buy
35,075
+15,005
+75% +$251K ﹤0.01% 1005
2025
Q2
$287K Sell
20,070
-60,350
-75% -$705K ﹤0.01% 1286
2025
Q1
$844K Buy
80,420
+9,990
+14% +$113K ﹤0.01% 929
2024
Q4
$853K Buy
70,430
+10,400
+17% +$136K ﹤0.01% 946
2024
Q3
$882K Buy
60,030
+10,950
+22% +$153K ﹤0.01% 937
2024
Q2
$708K Sell
49,080
-994
-2% -$15.9K ﹤0.01% 983
2024
Q1
$815K Sell
50,074
-1,000
-2% -$15.6K ﹤0.01% 928
2023
Q4
$761K Buy
51,074
+19,410
+61% +$220K ﹤0.01% 947
2023
Q3
$356K Buy
31,664
+6,394
+25% +$74.3K ﹤0.01% 1158
2023
Q2
$254K Buy
+25,270
New +$235K ﹤0.01% 1318
2020
Q2
Sell
-11,248
Closed -$252K 1690
2020
Q1
$252K Buy
+11,248
New +$308K ﹤0.01% 1075

Other funds holding ELAN

William Blair & Company's ELAN Position: Q2 2026 in Review

William Blair & Company sold out of Elanco Animal Health (ELAN) in Q2 2026, closing a stake of 18,165 shares — an estimated $435K sold.

William Blair & Company first reported a position in ELAN in Q1 2020 and held it in 13 quarters. The position peaked at $882K in Q3 2024. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • William Blair & Company reported no remaining Elanco Animal Health position as of Q2 2026 after selling out during the quarter.
  • William Blair & Company sold 18,165 Elanco Animal Health shares in Q2 2026, an estimated $435K.
  • William Blair & Company first reported a position in Elanco Animal Health in Q1 2020 and held it in 13 quarters.
  • William Blair & Company's Elanco Animal Health position peaked at $882K in Q3 2024.
  • 522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.